European Medicines Agency to host workshop on regulatory options in the fight against antimicrobial resistance
A workshop to discuss regulatory options for approval of new antibacterials for human use and actions to increase appropriate use of antibiotics will be held at the European Medicines Agency (EMA) on 8 November 2013.
The workshop, entitled ‘best use of medicines legislation to bring new antibiotics to patients and combat the resistance problem’, is organised by the EMA in collaboration with the European Commission. Participants will include representatives from national competent authorities, the European Centre for Disease Prevention and Control, the Infectious Diseases Society of America, community pharmacists, patient and healthcare-professional organisations, reimbursement bodies and the pharmaceutical industry.
The agenda covers the following areas:
- the European antimicrobial-resistance strategy;
- approval of new antibacterials;
- encouraging appropriate use of antibacterials;
- research and development of antimicrobials.
The event will be held from 09:00 to 17:00 (United Kingdom time) at the EMA in Canary Wharf, London. Participation is by invitation only. The workshop will be broadcast live on the EMA website, and the meeting outcomes and presentations will be published.
- Best use of medicines legislation to bring new antibiotics to patients and combat the resistance problem (08/11/2013)
- Antimicrobial resistance